R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model. (Q54360472)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model. |
scientific article |
Statements
R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model. (English)
Hideki Terashima
Mikio Kato
Masayuki Ebisawa
Hideki Kobayashi
Kanae Suzuki
Yoshikazu Nezu
Toshio Sada
12 April 2014
734
60-66